glp-1 drug exposure pharmaceutical companies 2025 What's next for innovation: A primer on the race reshaping pharma and chronic disease care GLP-1 Trends: Costs & Coverage

International agencies can assist by standardizing data standards, trial design, and adverse-event reporting

Testosterone is the exception

Most of the brain targeting agents were derived from a receptor- or carrier-mediated transcytosis process at the BBB

Details and Options: The usual B12 injection is cyanocobalamin 1 mg (1,000 mcg) administered intramuscularly (IM)

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 133,45 per year only 11,12 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF